What is it about?
This paper reports on the opportunistic yeast (Candida) species associated with HIV infection in 2 groups from South Africa and Cameroon and describes their response (or lack of it) to the anti-fungal drugs routinely administered for treatment or prophylaxis.
Why is it important?
Many HIV-associated Candida species have developed a resistance to the azole drugs. Regular reports of species prevalence and antimicrobial profiles are essential to control opportunistic infections in HIV patients.
Read the Original
This page is a summary of: Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon, Diagnostic Microbiology and Infectious Disease, June 2014, Elsevier, DOI: 10.1016/j.diagmicrobio.2013.09.016.
You can read the full text:
The following have contributed to this page